Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$52.17 - $70.2 $90.3 Million - $122 Million
-1,731,410 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$68.86 - $83.34 $7.12 Million - $8.61 Million
-103,333 Reduced 5.63%
1,731,410 $119 Million
Q1 2021

May 14, 2021

BUY
$76.15 - $111.94 $44.4 Million - $65.3 Million
583,642 Added 46.65%
1,834,743 $141 Million
Q4 2020

Feb 12, 2021

BUY
$96.85 - $148.25 $95 Million - $145 Million
981,264 Added 363.65%
1,251,101 $124 Million
Q3 2020

Nov 13, 2020

BUY
$122.47 - $213.56 $6.06 Million - $10.6 Million
49,516 Added 22.47%
269,837 $38.2 Million
Q2 2020

Aug 14, 2020

BUY
$185.52 - $231.25 $40.9 Million - $50.9 Million
220,321 New
220,321 $43.3 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.